
Gravel Pharma Private Limited
About Gravel Pharma Private Limited
Data last updated:
Gravel Pharma Private Limited is a private limited company based in Latur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2013PTC244491. Its GSTIN is 27AAFCG2516B1Z4 (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹9.7 Lakh. It is led by directors including Vishnudas Dwarkadas Bahndari and Uttam Dagdurao Deshmane.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhakti Nagar Latur Tq. Dist. Latur, Maharashtra, India – 413512.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.57 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹10.48 Lakh (net margin 10.5%) and EBITDA of ₹14.58 Lakh (EBITDA margin 14.6%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gravel Pharma Private Limited's registered office is in Latur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBhakti Nagar Latur Tq. Dist. Latur, Maharashtra, India – 413512
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Gravel Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gravel Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Gravel Pharma Private Limited, buy the company report.
Financials of Gravel Pharma Private Limited
FY 2025 filings availableGravel Pharma Private Limited reported revenue of ₹99.57 Lakh (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 4% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.6% | ||||
| Net Profit Margin | 10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gravel Pharma Private Limited, buy the company report.
Board of directors of Gravel Pharma Private Limited
Gravel Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishnudas Dwarkadas Bahndari Also directs: Latur CBCT LLP | Director | 14 Jun 2013 | 13 Years 5 Months | Current |
| Uttam Dagdurao Deshmane Also directs: Latur CBCT LLP | Director | 14 Jun 2013 | 13 Years 5 Months | Current |
| Sanjay Tukaram Jogdanad | Director | 14 Jun 2013 | 13 Years 5 Months | Current |
| Rahul Nandkishor Laturiya | Director | 14 Jun 2013 | 13 Years 5 Months | Current |
Auditor
Gravel Pharma Private Limited is audited by Chaudhary Malpani Bhandari & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chaudhary Malpani Bhandari & Co | FY 2023 | 124463W |
Shareholding
The shareholding of Gravel Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Gravel Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Gravel Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gravel Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gravel Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCG2516B1Z4 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gravel Pharma Private Limited, buy the company report.
Recent activity
Gravel Pharma Private Limited has 7 board changes on record since 2013: 4 appointments and 3 cessations. The latest: Dhanraj Dajisaheb Shitole ceased to be Director on 05 Jul 2023.
Frequently asked questions
Gravel Pharma is an active private limited company based in Latur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2013 (13+ years old) and is registered under CIN U74999MH2013PTC244491.
Gravel Pharma has 4 current directors:
- Vishnudas Dwarkadas Bahndari - Director
- Uttam Dagdurao Deshmane - Director
- Sanjay Tukaram Jogdanad - Director
- Rahul Nandkishor Laturiya - Director
The latest financial statements of Gravel Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gravel Pharma is 27AAFCG2516B1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gravel Pharma is U74999MH2013PTC244491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gravel Pharma was incorporated on 14 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Dhanraj Dajisaheb Shitole ceased to be Director on 05 Jul 2023. Eknath Uttamrao Kalkote ceased to be Director on 03 Oct 2022. Shivanand Mahadeo Dadge ceased to be Director on 23 Dec 2019. Gravel Pharma has 7 board changes on record in total.
The registered office of Gravel Pharma is at Bhakti Nagar Latur Tq. Dist. Latur, Maharashtra, India – 413512.
Gravel Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Gravel Pharma is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.

